Markets

Vaccines to curb F&P Healthcare sales

Dan Brunskill
Tue, 26 Jan 2021

Shares in Fisher & Paykel Healthcare surged last week as investors were swayed by sustained high sales numbers, but Forsyth Barr is warning demand may begin to fade as covid vaccinations roll out globally.The healthcare manufacturer saw its shares jump more than 5 percent on Friday on the news that revenue was up 73 percent in the nine months ended December, pulling the stock back above $35.Chief executive Lewis Gradon said high rates of covid-19 hospitalisations had driven strong demand for its hospital products, which are used as a front-...

Try free for 10 days

Trustworthy, balanced journalism every day from our growing team of New Zealand business reporters and commentators, plus more in our weekend magazine section, The Life.

Instant News Alerts based on keywords you choose or journalists you follow
Our Daily Digest of all stories at 6am, midday or 6pm
A custom library of your saved stories
An industry-leading search engine
Try for 10 days without paying and if you’re not convinced cancel with just two clicks.

Support quality New Zealand journalism by subscribing today.

Find out more

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Technology

Rocket Lab close to deal with US acquisition company — report

Staff reporters | Mon, 01 Mar 2021

Deal to take company public would reportedly value the US-New Zealand start up at US$4.1 billion.

Economy

Change self-isolation payments - Eaqub

Victoria Young | Mon, 01 Mar 2021

Shamubeel Eaqub says leave support payments should be linked to income if we want people to stay home.

Markets Wake Up Call

Auckland locked down again; bond markets cool down

Staff reporters | Mon, 01 Mar 2021

The NZ dollar is down sharply this morning after a shift back to ‘haven’ currencies and a drop in global bond yields over the weekend.

Vaccines to curb F&P Healthcare sales

Not convinced yet?

Your company has a subscription

Team